All stock lists
Unlock the score
Cooper Companies, Inc. (NASDAQ:COO)
US · Delayed Price · Currency is USD
Also listed: 0I3I.LHealthcare · Medical - Instruments & Supplies
60.98-0.23 (-0.38%)
Market cap
$11.6B
Insider Score
Health Score
Analyst consensus
Listed since
Jan 21, 1983
Website
Insider Score
/ 100
COO Insider Score
COOPER COMPANIES, INC. has a live Insider Score.
Scored on 5 qualifying trades from 3 insiders in the last 90 days.
Financial Health Score
Sound
From COO’s reported statements · Q3 2026 (trailing 12 months)
Profitability17 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $4.24B
- Net income
- $570.3M
- Net margin
- 13.5%
Leverage7 / 20
Heavily indebted for what it earns.
- Total debt
- $2.54B
- Cash
- $154.7M
- Net debt / EBITDA
- 2.62x
Liquidity10 / 20
Covers near-term obligations, without much room.
- Current assets
- $2.28B
- Current liabilities
- $1.87B
- Current ratio
- 1.22
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $1.03B
- Free cash flow
- $678.0M
- FCF margin
- 16.0%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 193.4M
- Share growth (1y)
- -3.6%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
COO Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jul 31, 2026 | Apr 30, 2026 | Jan 31, 2026 | Oct 31, 2025 | Jul 31, 2025 | Apr 30, 2025 |
| Revenue | 1.07 B | 1.08 B | 1.02 B | 1.07 B | 1.06 B | 1.00 B |
| Revenue Growth (YoY) | 0.56 % | 7.90 % | 6.16 % | 4.60 % | 5.73 % | 6.33 % |
| Cost of Revenue | 401.30 M | 346.10 M | 328.90 M | 464.20 M | 368.30 M | 323.20 M |
| Gross Profit | 664.90 M | 735.40 M | 695.20 M | 601.00 M | 692.00 M | 679.10 M |
| SG&A Expense | 401.30 M | 676.20 M | 390.20 M | 419.20 M | 421.70 M | 399.00 M |
| R&D Expense | 41.60 M | 42.50 M | 44.30 M | 41.40 M | 44.60 M | 45.50 M |
| Operating Expenses | 442.50 M | 766.40 M | 482.40 M | 460.60 M | 516.30 M | 494.30 M |
| Operating Income | 222.40 M | -31.00 M | 212.80 M | 140.40 M | 175.70 M | 184.80 M |
| Pretax Income | 201.80 M | -48.40 M | 192.20 M | 116.80 M | 151.90 M | 144.50 M |
| Tax Provision | -231.00 M | 29.50 M | 61.40 M | 32.20 M | 53.60 M | 56.80 M |
| Net Income | 432.80 M | -77.90 M | 130.80 M | 84.60 M | 98.30 M | 87.70 M |
| EPS (Basic) | 2.24 | -0.40 | 0.66 | 0.43 | 0.49 | 0.44 |
| EPS (Diluted) | 2.24 | -0.40 | 0.66 | 0.43 | 0.49 | 0.44 |
| Shares Outstanding | 193.40 M | 195.00 M | 196.70 M | 198.10 M | 200.60 M | 199.90 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.